Publicaciones en colaboración con investigadores/as de University of Rome Tor Vergata (9)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2022

  1. Editorial: The Impact of Angiogenic Growth Factors and Hypoxia on the Antitumor Immune Response

    Frontiers in Immunology

2021

  1. Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge

    Oncogene, Vol. 40, Núm. 23, pp. 4033-4049

2018

  1. The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life

    PLoS ONE, Vol. 13, Núm. 6

2011

  1. NPM1 gene deletions in myelodysplastic syndromes with 5q- and complex karyotype

    Haematologica, Vol. 96, Núm. 5, pp. 784

2007

  1. Calreticulin exposure dictates the immunogenicity of cancer cell death

    Nature Medicine, Vol. 13, Núm. 1, pp. 54-61

2004

  1. AIF deficiency compromises oxidative phosphorylation

    EMBO Journal, Vol. 23, Núm. 23, pp. 4679-4689

  2. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells

    Oncogene, Vol. 23, Núm. 1, pp. 311-316